Koers The Oncology Institute, Inc.
Aandelen
TOI
US68236X1000
Gezondheidszorgvoorzieningen & -diensten
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,175 USD | +0,43% | -15,22% | -42,65% |
Omzet 2024 * | 413 mln. 387 mln. | Omzet 2025 * | 483 mln. 453 mln. | Marktkapitalisatie | 91,4 mln. 85,82 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -50 mln. -46,94 mln. | Nettowinst (verlies) 2025 * | -36 mln. -33,8 mln. | EV/omzet 2024 * | 0,22 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,19 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | 800 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 66,69% |
Recentste transcriptie over The Oncology Institute, Inc.
1 dag | +0,43% | ||
1 week | -15,22% | ||
Lopende maand | -25,95% | ||
1 maand | -27,78% | ||
3 maanden | -45,33% | ||
6 maanden | -27,78% | ||
Lopend jaar | -42,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Virnich
CEO | Chief Executive Officer | 46 | 01-01-19 |
Mihir Shah
DFI | Director of Finance/CFO | 45 | 04-04-22 |
Jeremy Castle
COO | Chief Operating Officer | 41 | 05-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Barasch
CHM | Chairman | 70 | 12-11-21 |
Mark Pacala
BRD | Director/Board Member | 68 | 21-09-22 |
Bradford Hively
BRD | Director/Board Member | 45 | 01-01-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 1,17 | +0,86% | 62 791 |
18-04-24 | 1,23 | +5,13% | 37 757 |
17-04-24 | 1,17 | +0,86% | 62 791 |
16-04-24 | 1,16 | -2,52% | 60 129 |
15-04-24 | 1,19 | -7,03% | 158 090 |
slotkoers Nasdaq, 17 april 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,65% | 91,4 mln. | |
-11,84% | 87,46 mld. | |
+12,63% | 78,56 mld. | |
+10,85% | 29,37 mld. | |
-11,83% | 16,78 mld. | |
-4,17% | 16,01 mld. | |
-7,25% | 13,98 mld. | |
+0,92% | 12,31 mld. | |
-30,35% | 12,07 mld. | |
+22,45% | 11,06 mld. |